Compounds > threonine

threonine and Kidney Neoplasms

threonine has been researched along with Kidney Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, T; Isono, M; Okubo, K; Sato, A1
Camidge, DR; Ching, KA; Christensen, JG; Clark, JW; Diamond, JR; Eckhardt, SG; Kanteti, R; Lira, ME; LoRusso, PM; Salgia, R; Schoenmakers, EF; Varella-Garcia, M; Wilner, K; Xu, LG1
Anastasiadis, PZ; Copland, JA; Huveldt, D; Kourtidis, A; Yanagisawa, M1
Maxwell, SA; Rivera, A1
Al-Lamki, RS; Bradley, JA; Bradley, JR; Luo, D; Min, W; Pober, JS; Thiru, S; Vandenabeele, P; Wang, J1

Other Studies

5 other study(ies) available for threonine and Kidney Neoplasms

ArticleYear
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells.
    Anticancer research, 2018, Volume: 38, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Carcinoma, Renal Cell; Cell Line, Tumor; Cytochrome P-450 CYP3A Inhibitors; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Kidney Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Proteasome Inhibitors; Ritonavir; Threonine

2018
Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jun-01, Volume: 31, Issue:16

    Topics: Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Disease Progression; Drug Resistance, Neoplasm; Heterozygote; Humans; In Situ Hybridization, Fluorescence; Kidney Neoplasms; Male; Methionine; Middle Aged; Point Mutation; Proto-Oncogene Proteins c-met; Pyrazines; Receptor Protein-Tyrosine Kinases; Sequence Analysis, DNA; Threonine; Treatment Failure; Triazoles

2013
Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Blotting, Western; Breast Neoplasms; Carcinoma, Renal Cell; Catenins; Cell Transformation, Neoplastic; Delta Catenin; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Kidney Neoplasms; Phosphoproteins; Phosphorylation; Protein Binding; Serine; Threonine; Tissue Array Analysis; Tumor Cells, Cultured; Tyrosine

2015
Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas.
    The Journal of biological chemistry, 2003, Mar-14, Volume: 278, Issue:11

    Topics: Alanine; Apoptosis; Arginine; Blotting, Western; Carcinoma; DNA, Complementary; Flow Cytometry; Green Fluorescent Proteins; Histidine; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Luminescent Proteins; Oligonucleotides, Antisense; Phenylalanine; Plasmids; Proline Oxidase; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Threonine; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation

2003
TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:12

    Topics: Apoptosis; Biological Assay; Biopsy; Cell Proliferation; Down-Regulation; Enzyme Activation; Humans; In Situ Hybridization; In Situ Nick-End Labeling; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Kidney Tubules; MAP Kinase Kinase Kinase 5; Microscopy, Confocal; Models, Biological; Organ Culture Techniques; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Signal Transduction; Threonine; Up-Regulation

2005